Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trialHeikki Joensuu, Henrik Lindman, Riikka Huovinen et al.|The Lancet Oncology|2009Cited by 65